Characterizing prostate zonal shape changes associated with 5α-reductase inhibitors using MRI.

Area of Science:

• Urology
• Medical Imaging
• Pharmacology

Background:

• Benign prostatic hyperplasia (BPH) is common in elderly males, causing lower urinary tract symptoms (LUTS) and reduced quality of life.
• BPH involves prostate enlargement and increased angiogenesis, significantly impacting patient well-being.

Purpose of the Study:

• To analyze prostate zone shape alterations due to dutasteride treatment in BPH patients using MRI.
• To evaluate the efficacy of dutasteride, a 5α-reductase inhibitor, in modifying prostate morphology.

Main Methods:

• Retrospective analysis of MRI scans from 19 dutasteride-treated and 33 non-treated BPH patients.
• Prostate transition and peripheral zones were landmarked using TPSDIG v2.04.
• Generalized Procrustes Analysis was employed for statistical shape analysis.

Main Results:

• Dutasteride significantly altered the transition zone shape, characterized by posterior narrowing.
• Statistically significant differences in transition zone shape were observed between treated and untreated groups, both initially and post-treatment.

Conclusions:

• 5α-reductase inhibitors like dutasteride induce favorable shape changes in the prostate transition zone.
• These morphological changes correlate with reduced prostate volume and symptom amelioration in BPH patients.